Skip to content

Clinical trials

Phase 3 Stroke trials in Colombia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Colombia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20071
20081
20091
20101
20111
20133
20143
20181
20191
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Boehringer Ingelheim2
Pfizer2
Sanofi2
AstraZeneca1
Bayer1
CSL Behring1
Daiichi Sankyo1
Eli Lilly and Company1
Fundación Cardiovascular de Colombia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke19
Myocardial Infarction10
Cardiovascular Diseases8
Atrial Fibrillation5
Heart Diseases4
Acute Coronary Syndrome3
Coronary Artery Disease3
Hyperlipidemias3
Atherosclerosis2
Embolism2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.